Needle-Stick in Laundry: An HBsAg-Positive Source, an Unknown HIV Status and a Pregnant Worker
A 41-year-old housekeeping and laundry worker at a private hospital in Jakarta sustains a deep needle-stick while compressing a linen bag; the needle is visibly blood-stained. She reports it five hours later, at the end of her shift. Her hepatitis B vaccination record shows three doses completed eight years ago, with no anti-HBs titre on file; she is 12 weeks pregnant. The source is later identified as a medical-surgical inpatient known to be HBsAg-positive, whose HIV status is unknown and who has not consented to testing. The hospital clinic stocks hepatitis B immunoglobulin but no HIV post-exposure prophylaxis; the referral hospital 40 minutes away has it. The nurse manager advises 'waiting for the source's HIV result before starting anything', and reminds the doctor that the ward is short-staffed. The worker asks whether the treatment will harm the baby.
1. What should be done for this worker in the first hours, and is the nurse manager's advice to wait correct?
Read the worked answer
Wound care first. Wash the site with soap and running water, allow it to bleed, do not squeeze or use bleach or caustic agents, then cover. Take baseline bloods: HBsAg, anti-HBs, anti-HCV, HIV, with liver and renal function for later drug dosing, and check tetanus status.
Hepatitis B - act now. She has three documented doses but no anti-HBs titre, so her immune status is unknown. For a significant percutaneous exposure to an HBsAg-positive source, the safe course is to give hepatitis B immunoglobulin as soon as possible (ideally within 12 hours, certainly within 24 hours and up to 7 days) together with a booster vaccine dose, while the anti-HBs result is pending. If anti-HBs returns at ≥10 mIU/mL, the immunoglobulin was unnecessary but harmless; if it is below 10, the immunoglobulin was essential. Waiting for the titre before protecting her would be the wrong order of operations.
HIV - do not wait. The source's HIV status is unknown and the exposure is significant. The correct decision is to start PEP immediately, because efficacy falls with delay and is largely lost after 72 hours; if the source is later confirmed HIV-negative, PEP is stopped. The nurse manager's advice inverts the logic: PEP decisions are made on the exposure and the source's risk, not on a result that may take days.
Tetanus. Give a booster if her status is incomplete or unknown.
Logistics. If the clinic has no PEP, send her to the referral centre now with a written request and follow up the same day; a 40-minute journey is not a reason to delay a 28-day course.
2. She is 12 weeks pregnant and asks whether the treatment will harm the baby. What do you advise, and what monitoring is needed?
Read the worked answer
Reasoning. The question must be answered with the risk of doing nothing on one side and the risk of the drugs on the other. Untreated HIV acquisition in pregnancy carries a substantial risk of maternal disease and vertical transmission; hepatitis B in a non-immune adult carries a risk of chronic carriage and, later, cirrhosis and hepatocellular carcinoma. Against that, the recommended PEP regimen - tenofovir disoproxil fumarate plus lamivudine plus dolutegravir - is considered compatible with pregnancy, and dolutegravir in particular is now recommended in pregnancy in international guidance. Hepatitis B immunoglobulin and recombinant hepatitis B vaccine are both safe in pregnancy and are routinely given to pregnant women who need them.
What I would tell her. The medicines are recommended in pregnancy, the alternative - not taking them - is more dangerous for her and for the baby, and the decision can be reviewed as soon as the source's status is known. Document the counselling and her agreement.
Monitoring. Baseline renal function and urinalysis before tenofovir, review at two weeks for side effects and adherence, repeat renal function during the course, and coordinate with the obstetrician and the HIV/ID team. Complete the 28-day course; do not stop early on the basis of an intermediate result without specialist advice. Arrange follow-up HIV testing at 6 weeks, 3 months and 6 months, and hepatitis B serology at 1–2 months after the vaccine booster to confirm a response. If she seroconverts, she needs antenatal and HIV care, not reassurance.
3. Apart from this individual's treatment, what system failures does this incident reveal, and what should the occupational health service change?
Read the worked answer
The five-hour delay. A worker injured at the start of a shift reported at the end of it. That usually signals fear of blame, ignorance of the reporting route, or an unwelcoming clinic - all of which suppress reporting and hide future exposures. The service needs a visible, blame-free reporting route available on every shift, with a named responder and a telephone number on the ward.
PEP not stocked. A hospital that cannot provide HIV PEP within the golden window is not equipped to protect its own staff. The clinic should hold starter packs of the recommended regimen, with a written protocol, a designated prescriber and a stock-check system, and an agreed pathway to the referral centre for the remainder of the course.
Source testing and consent. The source patient's HIV status was unknown and consent had not been obtained. The service needs a standing procedure for confidential source testing after an exposure, with counselling, and a rule that PEP is never delayed pending that result.
Prevention upstream. Review sharps disposal at the point of use, eliminate manual compression of linen bags and other procedures that put hands near discarded needles, introduce safety-engineered devices where feasible, and audit needle-stick rates by ward and by device.
Reporting and compensation. The incident is a work accident: it should be reported to HR and the Disnaker within the statutory period and claimed under JKK/BPJS Ketenagakerjaan, with the exposure recorded in the worker's medical file. A quarterly review of sharps injuries with feedback to wards closes the loop; without it, the same incident recurs with a different cleaner.